Champions Oncology Inc., of Hackensack, N.J., added Dan Mendelson and Arthur G...Cytori Therapeutics Inc., of San Diego, named Steven Kesten executive vice president and chief medical officer...OncoSec Medical Inc., of San Diego, appointed Sanjiv S. Agarwala, Axel Hauschild, Kim A. Margolin and Vernon K. Sondak to its new melanoma advisory board (MAB) and named Adil I. Daud chairman of the MAB

Anergis, of Eplinges, Switzerland, named Gilles Della Corte director of clinical development and Eva Castagnetti director of product development...Curis Inc., of Lexington, Mass., appointed Ali Fattaey president and chief operating officer...Mylan Inc., of Pittsburgh, added Melina Higgins and Rajiv Malik to its board

Probiodrug AG, of Halle, Germany, appointed Ronald Black chief medical officer and Inge Lues chief development officer...Rexahn Pharmaceuticals Inc., of Rockville, Md., named Peter D. Suzdak CEO and Chang AHN chief scientist...Spectrum Pharmaceuticals Inc., of Henderson, Nev., named Joseph Turgeon senior vice president and chief commercial officer

DCPrime BV, of Amsterdam, the Netherlands, named Marcel Zwaal CEO and Anthony Hall chief medical officer...Theratechnologies Inc., of Montreal, appointed Luc Tanguay interim president and CEO...Zyngenia Inc., of Gaithersburg, Md., added Christian Itin and Jason Rhodes to its board

Named Howard Rosen vice president, sales and marketing, and Thomas Bendix Mortensen vice president, sales and marketing in Europe

Eli Lilly and Co., of Indianapolis, named Michael Harrington senior vice president and general counsel...Vertex Pharmaceuticals Inc., of Cambridge, Mass., appointed Stuart Arbuckle executive vice president and chief commercial officer

Mark Oki senior vice president, finance and chief financial officer...Shire plc, of Dublin, Ireland, appointed Soren Tulstrup senior vice president and franchise lead, MPS for its human genetic therapies business...Silence Therapeutics plc, of London, named Jerry Randall executive chairman and Ali Mortazavi director of corporate strategy

NovImmune SA, of Plan-Les-Ouates, Switzerland, added Michael Steinmetz to its board and appointed David Slack head of corporate and business development...Savient Pharmaceuticals Inc., of East Brunswick, N.J., appointed Louis Ferrari president and CEO...Xenetic Biosciences plc, of London, added Subash Kapre and Thomas Ulich to its scientific advisory board

A.P. Pharma Inc., of Redwood City, Calif., added Barry Quart and Stephen Davis to it board...Saladax Biomedical Inc., of Bethlehem, Pa., named Kevin Harter president and CEO...Sequenom Inc., of San Diego, named Carolyn Beaver vice president and chief accounting officer

Generex Biotechnology Corp., of Worcester, Mass., added Keith Knutson and James Mule to its scientific advisory board...PolyTherics Ltd., of London, added Anker Lundemose and Nigel Pitchford to its board...Promedior Inc., of Malvern, Pa., appointed Suzanne Bruhn president and CEO

Tris Pharma Inc., of Monmouth Junction, N.J., named Amanda Wohlleber vice president of scale-up and technical services and Rajul Parikh vice president, operations...Vaximm AG, of Basel, Switzerland, and Mannheim, Germany, appointed Jean Paul Prieels to its board...Ziopharm Oncology Inc., of New York, appointed Jason Amello executive vice president and chief financial officer

AMAG Pharmaceuticals Inc., of Lexington, Mass., appointed William Heiden president and CEO...Blueprint Medicines, of Cambridge, Mass., named George Demetri clinical advisor and member of the scientific advisory board...Cynapsus Therapeutics Inc., of Toronto, nominated Perry Molinoff, Thomas Picone and President and CEO Anthony Giovinazzo to its board

XOMA Corp., of Berkeley, Calif., named Paul Rubin senior vice president, research and development

and Santosh Varghese vice president of medical affairs...The company promoted Barbara Troupin to vice president, scientific communication and risk management...named CFO Timothy Morris senior vice president, global corporate development and finance

AcelRx Pharmaceuticals Inc., of Redwood City, Calif., named Kim Gaumer vice president, regulatory affairs and quality assurance...Array BioPharma Inc., of Boulder, Colo., appointed Howard Holden vice president of regulatory affairs and quality assurance...Avion Pharmaceuticals LLC, of Atlanta, appointed Michael Sullivan vice president, sales and marketing

Adventrx Pharmaceuticals Inc., of San Diego, formed a regulatory advisory board (RAB) and appointed Cindy Dinella and Bonnie Hepburn to the RAB, with Frank Sasinowski as RAB advisor...InDex Pharmaceuticals AB, of Stockholm, Sweden, appointed Pernilla Sandwall head of clinical operations and Thomas Knittel chief medical officer

Pluristem Therapeutics Inc., of Haifa, Israel, appointed Jeffrey Olin, Manesh Patel, Petra Reinke and J. Andre Schmidt-lucke to its new peripheral artery disease steering committee...PTC Therapeutics Inc., of South Plainfield, N.J., named Claudia Hirawat president and Mark Boulding executive vice president and chief legal officer

Constellation Pharmaceuticals Inc., of Cambridge, Mass., named Keith Dionne president and CEO and Mark Goldsmith executive chairman of the board...Intermune Inc., of Brisbane, Calif., added Jean-Jacques Bienaime and Frank Verwiel to its board...OvaScience, of Cambridge, Mass., added Jeffrey Capello and John Simon to its board

3SBio Inc., of Shenyang, China, named Jing Lou board chairman and added Dongmei Su to its board...Anaphore Inc., of La Jolla, Calif., added Peppi Prasit and Raymond Stevens to its board...Silence Therapeutics plc, of London, appointed Detlef Schuppan and Massimo Pinzani to its newly created scientific advisory board